The mission of the Samuel Waxman Cancer Research Foundation (SWCRF) is to eradicate cancer by funding collaborative cross-institutional research that identifies and corrects abnormal gene function that causes cancer. This research is the basis for developing minimally toxic treatments for patients, which is particularly crucial for children and seniors battling cancer.

In this video, SWCRF Founder and CEO Dr. Samuel Waxman explains the mission of the foundation:

 

 

Since 1976 the SWCRF has awarded nearly $100 million to more than 200 researchers worldwide. Here's a video that tells the story of how we brought together the world's brightest scientific minds to find a cancer cure:

 

 

Key Facts About SWCRF:

 

  • Based in New York City, the Samuel Waxman Cancer Research Foundation was founded in 1976 by Samuel Waxman, M.D., Distinguished Service Professor and Professor of Medicine, ‚Ä®Division of Hematology/Oncology, Department of Medicine, ‚Ä®Icahn School of Medicine at Mount Sinai.

 
  • SWCRF focuses on funding cutting-edge research that uncovers cancer-causing abnormal gene function.

 
  • A key goal of SWCRF is to develop minimally toxic treatments based on correcting cancer-causing gene function associated with all forms of cancer.

 
  • Since abnormal gene function increases with age, this approach is particularly effective for seniors battling cancer.

 
  • Since its inception, SWCRF has invested approximately $100 million in cancer research.

 
  • Through our “Institute Without Walls,” we fund a network of 60 research laboratories directed by the brightest scientific minds who collaborate throughout North America, Asia and Europe.